Like much else in US patent litigation, the cost of IPRs skews the system heavily against the small guy

@IAM_Alerts RT @AMorrisReports: Moderna, having become one of the most valuable pharmaceutical businesses on the planet, and with a major shortage of v… Read more

@IAM_Alerts In an exclusive interview, ZTE's Marco Tong declines to comment on company’s rumoured suit against a Chinese phone… https://t.co/GpVcYKpWeg Read more

@IAM_Alerts BlackBerry patent sale price agreed, deal 80% certain this quarter, says company's CEO John Chen… https://t.co/klOCncfg4Q Read more

@IAM_Alerts Beijing wants cross-border IP trade to increase: policymakers target $54 billion in IP royalty imports/exports by 2… https://t.co/9oPIjvEF8e Read more